Skip to main content
. 2012 Apr 6;3(5):422–426. doi: 10.1021/ml300056y

Figure 2.

Figure 2

Inhibition of human NAAA by ARN077. (A) Concentration–response curve for inhibition of recombinant hNAAA by ARN077 after 30 min of incubation. (B) Michaelis–Menten analysis of ARN077 (vehicle, ●; 10 nM ARN077, ■; and 30 nM ARN077, ▲). (C) Preincbation time course of ARN077 (100 nM). (D) Reversibility study of ARN077 (vehicle, open bars; ARN077, black bars). *p < 0.05 ARN077 postdialysis vs vehicle postdialysis; **p < 0.01 ARN077 postdialysis vs ARN077 predialysis; and ***p < 0.001 ARN077 predialysis vs vehicle predialysis.

HHS Vulnerability Disclosure